Literature DB >> 22094438

Clinical application of an extracellular phosphate-buffered solution (EP-TU) for lung preservation: preliminary results of a Japanese series.

Yoshinori Okada1, Yuji Matsumura, Hiroshi Date, Toru Bando, Takahiro Oto, Tetsu Sado, Yasushi Hoshikawa, Masafumi Noda, Hisashi Oishi, Takashi Kondo.   

Abstract

PURPOSE: We evaluated the effect of an extracellular phosphate-buffered lung preservation solution (EP-TU solution) on acute postoperative graft function and recipient survival in a Japanese series of cadaveric lung transplantation.
METHODS: The subjects were ten patients who received lung grafts preserved with EP-TU solution at three of four designated lung transplant centers between 2000 and 2005. Three of the patients underwent single lung transplantation and seven underwent bilateral lung transplantation. Postoperative graft function was evaluated by primary graft dysfunction (PGD) grade (0-3), arterial oxygen tension/inspired oxygen fraction (PaO(2)/FiO(2)) ratio, and the previously reported chest roentgenogram score (CRS, 0-4) during the first 48 h after intensive care unit admission. Survival rates were also calculated.
RESULTS: The average graft ischemic times for the first and second grafts were 431 and 571 min, respectively. The average PGD grade ranged from 0.5 to 1.0 and the average PaO(2)/FiO(2) ratio ranged from 350 to 400 Torr during the 48 h. The average CRS was always under 1.0. Survival rates at 30 days and 5 years were 90 and 80%, respectively.
CONCLUSIONS: EP-TU solution promoted excellent postoperative lung graft function and enhanced recipient survival rates, despite a long average preservation time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094438     DOI: 10.1007/s00595-011-0052-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

Review 1.  Lung preservation.

Authors:  Marc de Perrot; Shaf Keshavjee
Journal:  Semin Thorac Cardiovasc Surg       Date:  2004

2.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

Review 3.  New trends in lung preservation: a collective review.

Authors:  R J Novick; A H Menkis; F N McKenzie
Journal:  J Heart Lung Transplant       Date:  1992 Mar-Apr       Impact factor: 10.247

4.  The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009.

Authors:  Jason D Christie; Leah B Edwards; Paul Aurora; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; David O Taylor; Anna Y Kucheryavaya; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2009-10       Impact factor: 10.247

5.  Experimental orthotopic lung transplantation model in rats with cold storage.

Authors:  Ryujiro Sugimoto; Atsunori Nakao; Itaru Nagahiro; Junichi Kohmoto; Seiichiro Sugimoto; Mikio Okazaki; Masaomi Yamane; Hidetoshi Inokawa; Takahiro Oto; Kazunori Tahara; Jianghua Zhan; Yoshifumi Sano; Kenneth R McCurry
Journal:  Surg Today       Date:  2009       Impact factor: 2.549

Review 6.  Impact of lung preservation solutions, Euro-Collins vs. low-potassium dextran, on early graft function: a review of five clinical studies.

Authors:  Yoshinori Okada; Takashi Kondo
Journal:  Ann Thorac Cardiovasc Surg       Date:  2006-02       Impact factor: 1.520

7.  Perfadex for clinical lung procurement: is it an advance?

Authors:  Tarek M Aziz; Thaseegaran M Pillay; Paul A Corris; Jonathan Forty; Colin J Hilton; Asif Hasan; John H Dark
Journal:  Ann Thorac Surg       Date:  2003-03       Impact factor: 4.330

8.  Pulmonary graft preservation: a worldwide survey of current clinical practice.

Authors:  D N Hopkinson; M S Bhabra; T L Hooper
Journal:  J Heart Lung Transplant       Date:  1998-05       Impact factor: 10.247

9.  Early expression of adhesion molecules after lung transplantation: evidence for a role of aggregated P-selectin-positive platelets in human primary graft failure.

Authors:  Magali Colombat; Yves Castier; Guy Lesèche; Pierre Rufat; Hervé Mal; Gabriel Thabut; Michel Fournier; Odile Groussard; Claude Degott; Anne Couvelard
Journal:  J Heart Lung Transplant       Date:  2004-09       Impact factor: 10.247

10.  A study of preservation solution for 48- and 96-hour simple hypothermic storage of canine lung transplants.

Authors:  M Handa; S Fujimura; T Kondo; T Ichinose; Y Shiraishi; T Nakada
Journal:  Tohoku J Exp Med       Date:  1989-11       Impact factor: 1.848

View more
  4 in total

1.  Clinical application of ET-Kyoto solution for lung transplantation.

Authors:  Masaki Ikeda; Toru Bando; Tetsu Yamada; Masaaki Sato; Toshi Menjyu; Akihiro Aoyama; Toshihiko Sato; Fengshi Chen; Makoto Sonobe; Mitsugu Omasa; Hiroshi Date
Journal:  Surg Today       Date:  2014-05-22       Impact factor: 2.549

2.  Successful bilateral lung transplantation after 16 h of lung preservation with EP-TU solution: report of a case.

Authors:  Hisashi Oishi; Yoshinori Okada; Yoshikatsu Saiki; Tetsu Sado; Masafumi Noda; Yasushi Hoshikawa; Chiaki Endo; Akira Sakurada; Sumiko Maeda; Miki Akiba; Kunihiko Hoshi; Takashi Kondo
Journal:  Surg Today       Date:  2014-05-20       Impact factor: 2.549

3.  Mesenchymal stem cells attenuate ischemia-reperfusion injury after prolonged cold ischemia in a mouse model of lung transplantation: a preliminary study.

Authors:  Tatsuaki Watanabe; Yasushi Hoshikawa; Naoya Ishibashi; Hirotoshi Suzuki; Hirotsugu Notsuda; Yui Watanabe; Masafumi Noda; Masahiko Kanehira; Shinya Ohkouchi; Takashi Kondo; Yoshinori Okada
Journal:  Surg Today       Date:  2016-08-02       Impact factor: 2.549

Review 4.  Organ preservation: from the past to the future.

Authors:  Lei Jing; Leeann Yao; Michael Zhao; Li-Ping Peng; Mingyao Liu
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.